Background and Aims: The objective of this study was to assess the frequency of specific-point mutations inN-ras of the RAS gene family in a group of Kashmiri patients with bladder cancer and to observe any associationwith clinicopathological parameters. Methods: Paired tumor and normal tissue specimens of 55 consecutivepatients with urothelial cell carcinoma were screened and DNA was extracted for detection of N-ras activatingmutations in exons 1 and 2. In addition, blood was also collected from all the cases to rule out any germ linemutation. Results: Specific point mutations of activated N-ras were detected in 9% (5 of 55) of the bladdercancer patients, all being missense. The base substitutions identified included three transversions (two G toTand one A to T) and two transitions ( A-G). Sixty % of the mutations were detected in codon 61 and 40% incodon 12. No significant correlations were found between the mutations and clinical features. Conclusion:Although N-ras gene mutation might be one of the mechanisms underlying oncogenesis of urothelial cancer, itseems to be a relatively rare event in Kasmiris, pointing to involvement of different etiological factors in theinduction of bladder tumor in this population
(2009). Screening of N-ras Gene Mutations in Urothelial Cell Carcinomas of the Urinary Bladder in the Kashmiri Population. Asian Pacific Journal of Cancer Prevention, 10(6), 1063-1066.
MLA
. "Screening of N-ras Gene Mutations in Urothelial Cell Carcinomas of the Urinary Bladder in the Kashmiri Population". Asian Pacific Journal of Cancer Prevention, 10, 6, 2009, 1063-1066.
HARVARD
(2009). 'Screening of N-ras Gene Mutations in Urothelial Cell Carcinomas of the Urinary Bladder in the Kashmiri Population', Asian Pacific Journal of Cancer Prevention, 10(6), pp. 1063-1066.
VANCOUVER
Screening of N-ras Gene Mutations in Urothelial Cell Carcinomas of the Urinary Bladder in the Kashmiri Population. Asian Pacific Journal of Cancer Prevention, 2009; 10(6): 1063-1066.